Personalising cancer medicine with prognostic markers

EBioMedicine. 2021 Oct:72:103577. doi: 10.1016/j.ebiom.2021.103577. Epub 2021 Sep 23.

Authors

David J Kerr¹, Li Yang²

Affiliations

¹ Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom; Oxford-Sichuan Gastrointestinal Cancer Centre, University of Oxford, Oxford OX3 9DS, United Kingdom. Electronic address: david.kerr@ndcls.ox.ac.uk.
² Oxford-Sichuan Gastrointestinal Cancer Centre, University of Oxford, Oxford OX3 9DS, United Kingdom; Department of Hepatology and Gastroenterology, Sichuan University, Chengdu, China.

No abstract available

MeSH terms

Biomarkers, Tumor / genetics*
Humans
Neoplasms / genetics*
Neoplasms / therapy
Precision Medicine*
Prognosis*

Substances

Biomarkers, Tumor